Lactate Dehydrogenase (LDH), Body Fluid
Lactate Dehydrogenase (LDH) is an enzyme produced in the liver that catalyzes the conversion of lactate and pyruvate in the presence of NAD/NADH. It is widely distributed in all tissues and body fluids. Because LDH is highly concentrated in RBCs, spuriously elevated serum levels occur if RBCs are hemolyzed during specimen collection. Serum LDH is not a useful liver disease test and it is not specific enough for the diagnosis of hemolytic or megaloblastic anemias. In viral hepatitis and chronic alcoholism LDH can be useful when used in combination with other diagnostic tests such as MCV, triglyceride, alkaline phosphatase, AST, ALT, GGT, bilirubin, etc. In the diagnosis of myocardial infarction, serum LDH has mostly been replaced by cardiac troponin and CK-MB levels. An LDH:AST ratio of greater than 18 is an indication of pancreatic necrosis. LDH can be also measured in body fluids and compared with the level found in serum. If the LDH level in a fluid is approximately equal to or greater than the serum level this might indicate an inflammatory process.
- As an aid in diagnosis of cardiac muscle injury, especially in acute myocardial infarction
- As an aid in diagnosis of kidney injury such as kidney necrosis
- As an aid in diagnosis of liver injury, such as liver cirrhosis
- As an aid in diagnosis of myeloproliferative disorders, leukemias, and lymphomas
- As an aid in diagnosis of anemia, such as hemolytic anemia and megaloblastic anemias
Increased in:
- Tissue necrosis such as acute injury of cardiac muscle
- Kidney damage and/or necrosis
- Skeletal muscle necrosis
- Liver necrosis
- Lung injury
- Skin necrosis
- Various carcinomas
- Pneumocystis jiroveci pneumonia
- Chronic lymphocytic leukemia and some lymphomas
- Marked elevations occur in hemolytic anemias
- Vitamin B12 deficiency anemia
- Folate deficiency anemia
- Thrombotic thrombocytopenic purpura
- In chronic inflammatory diseases such as hepatitis, cirrhosis, obstructive jaundice, renal disease, musculoskeletal disease, and congestive heart failure (CHF)
Decreased in:
- Drugs such as clofibrate, fluoride (low dose)
| Reference Ranges (U/L) | |
| Serum | U/L |
| Neonate | 415–690 |
| Adult |
140–280 |
| CSF | <20 |
+ Refrigerated - Unacceptable
+ Frozen - Unacceptable
- J Infect Chemother. 2011 Nov 15. [PMID: 22080202]
- Clin Biochem. 1995 Feb;28(1):1-29. [PMID: 7720223]
- Eur Respir J. 1996 Aug;9(8):1736-42. [PMID: 8866602]
- Curr Probl Cancer. 1991 Nov-Dec;15(6):299-360. [PMID: 1760927]
- Clin Lymphoma. 2005;6:21. [PMID: 15989702]
- Curr Opin Oncol 2005;17:167. [PMID: 15725923]
- Expert Rev Mol Diagn. 2005;5:65. [PMID: 15723593]
- Haematologica. 2005;90:391. [PMID: 15749671]
- Anderson SC, Cockayne S. Clinical Chemistry: concepts and applications. Philadelphia. W.B. Saunders Company (1993).
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).